These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4286153)

  • 1. The excretion of type 1 poliovirus after challenge following primary immunization with quadruple, Salk and Sabin vaccines.
    Mon Bull Minist Health Public Health Lab Serv; 1965 Nov; 24():365-9. PubMed ID: 4286153
    [No Abstract]   [Full Text] [Related]  

  • 2. Field trial on the efficacy of oral Sabin vaccine versus Salk polio vaccine.
    Imam IZ
    Dev Biol Stand; 1981; 47():215-21. PubMed ID: 7014298
    [No Abstract]   [Full Text] [Related]  

  • 3. Sabin and Salk poliovirus vaccine: vice versa.
    Cohen HH
    Acta Leiden; 1987; 56():65-83. PubMed ID: 3329800
    [No Abstract]   [Full Text] [Related]  

  • 4. Salk vs. Sabin controversy.
    Puliyel JM
    Indian Pediatr; 1987 Aug; 24(8):690. PubMed ID: 3443513
    [No Abstract]   [Full Text] [Related]  

  • 5. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR
    Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excretion of poliomyelitis virus types 1, 2 and 3 before and after vaccination with the Sabin vaccine in children's institutions].
    Topciu V; Gherman D; Plavoşin-Babuşceac L; Iutchin I; Munteanu N; Ionesco C
    Arch Roum Pathol Exp Microbiol; 1966 Sep; 25(3):791-8. PubMed ID: 4292260
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
    J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation and subtype identification of poliovirus strains following the administration of Sabin vaccine].
    Candeias JA
    Rev Saude Publica; 1969; 3(2):183-201. PubMed ID: 4313547
    [No Abstract]   [Full Text] [Related]  

  • 13. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
    Assaad F
    Dev Biol Stand; 1981; 47():275-82. PubMed ID: 6262152
    [No Abstract]   [Full Text] [Related]  

  • 14. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.
    Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine.
    Kucharská Z; Srámová H; Zdrazílek J
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):74-82. PubMed ID: 6282962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. I. SCHEDULE OF THIS TRIAL AND EXCRETION OF VIRUS IN FECES AFTER THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    URASAWA S; OGAWA M; KANNO T
    Sapporo Igaku Zasshi; 1963 Mar; 23():194-201. PubMed ID: 14057342
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.